Article
The mRNA vaccine expressing fused structural protein of PRRSV protects piglets against PRRSV challenge
25 Apr 2025
Abstract excerpt
The swine industry experiences substantial economic losses annually due to the porcine reproductive and respiratory syndrome virus (PRRSV). The limited protective efficacy of existing commercial vaccines against epidemic PRRSV underscores the urgent need for innovative solutions. The mRNA vaccines , which elicit robust immune responses, have emerged as a promising avenue in vaccine development. In this study, two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
